Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025, for Corteva, Inc. and its subsidiary EIDP, Inc. Corteva operates in two reportable segments: Seed and Crop Protection. The filing notes that EIDP is a wholly-owned subsidiary of Corteva, with EIDP's preferred stock classified as noncontrolling interest at the Corteva level. On October 1, 2025, Corteva announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies via a tax-free spin-off.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Net Sales | $2,618 million | $2,326 million | $13,491 million | $12,930 million |
| Net Income (Loss) Attributable to Corteva | $(320) million | $(524) million | $1,646 million | $948 million |
| Diluted EPS (Continuing Ops) | $(0.46) | $(0.76) | $2.54 | $1.29 |
| Operating EBITDA (Non-GAAP) | $49 million | $(100) million | $3,402 million | $2,851 million |
| Cash and Cash Equivalents | $2,509 million | $2,421 million | $2,509 million | $2,421 million |
| Total Debt | $4,373 million | $5,716 million | $4,373 million | $5,716 million |
| Free Cash Flow (9M) | $(1,310) million | $(2,287) million | $(1,310) million | $(2,287) million |
Note: Free Cash Flow calculated as Operating Cash Flow (Continuing Ops) less Capital Expenditures.
Material Changes vs. Prior Period
- Revenue Growth: Q3 2025 net sales increased 13% year-over-year, driven by a 12% volume increase and favorable currency impacts, partially offset by a 1% price decline. YTD sales grew 4%.
- Profitability Improvement: Q3 2025 net loss narrowed significantly to $(320) million from $(524) million in Q3 2024. Operating EBITDA improved from a loss of $(100) million to a profit of $49 million.
- Segment Performance:
- Seed: Q3 sales rose 33% to $917 million, driven by volume growth in Latin America (safrinha season) and EMEA. Segment operating EBITDA improved to $(193) million from $(320) million.
- Crop Protection: Q3 sales increased 4% to $1,701 million. Segment operating EBITDA rose 13% to $279 million, aided by raw material deflation and productivity savings.
- Restructuring: Net restructuring and asset-related charges decreased to $30 million in Q3 2025 from $32 million in Q3 2024, primarily related to the Crop Protection Operations Strategy Restructuring Program.
- Debt Levels: Total debt decreased to $4.37 billion from $5.72 billion at the end of 2024, reflecting the repayment of maturing senior notes and lower short-term borrowings compared to peak seasonal needs.
Guidance, Outlook, Risks, and Unusual Items
- Proposed Separation: Management announced plans to spin off Seed and Crop Protection into two independent companies. This introduces execution risks, potential disruption to operations, and uncertainty regarding the final capital structure and tax treatment.
- Legal and Environmental Contingencies:
- PFAS Litigation: Significant exposure remains regarding legacy PFAS liabilities. A proposed NJ Statewide Settlement involves aggregate payments of $875 million over 25 years (Corteva's share approx. $254 million net present value). Discontinued operations recorded an after-tax charge of $(87) million YTD 2025 related to PFAS remediation and litigation.
- Bayer Dispute: Legal proceedings regarding E3 soybeans and AAD-1 technology are paused through mid-January 2026 to enable a comprehensive resolution.
- FTC Investigation: Ongoing antitrust investigation and related private class actions regarding Crop Protection products; trials expected to begin in 2027.
- Capital Allocation: The company returned approximately $1.1 billion to shareholders YTD 2025 via dividends and share repurchases. A $3 billion share repurchase program remains active.
- Unusual Items: YTD 2025 included a $98 million benefit from insurance proceeds and a $37 million charge for AltEn facility remediation, both excluded from Operating EBITDA.
Investor Verification Checklist
- Separation Timeline: Verify the progress of the proposed spin-off, including regulatory approvals and the finalization of the capital structure for the two new entities.
- PFAS Liability Exposure: Monitor the status of the NJ Statewide Settlement court approval and the potential for additional state-level settlements or litigation costs exceeding current accruals.
- Argentina Operations: Assess the impact of continued currency devaluation and government restrictions on cash repatriation from Argentina, which contributes ~3% to annual net sales.
- Working Capital Seasonality: Confirm the trajectory of accounts receivable and inventory levels as the company moves through the seasonal peak of the agricultural cycle.
- Debt Covenant Compliance: Verify continued compliance with the 0.60 total indebtedness to total capitalization ratio under revolving credit facilities.